Cantor Fitzgerald reiterates Overweight rating on Salesforce, $300 price target
Cantor Fitzgerald maintained an Overweight rating on Salesforce with a $300 price target, suggesting a 23.7% upside from the Oct 20 close. The firm expects the BRZE acquisition to add over $1 billion in subscription revenue by FY29, driving growth and profitability.
How this was made
The 30-second read
Why it matters
The upgrade and higher target are likely to attract buying interest, especially given the projected $1B revenue boost from the BRZE acquisition.
Market read
Analyst upgrade with a substantial price target increase can drive short-term buying pressure on CRM.
What to watch
Potential dilution from financing the acquisition and competitive pressure from other CRM providers.
Background
Cantor Fitzgerald issued an analyst note reiterating an Overweight stance on Salesforce (CRM) and raised its price target to $300.
Ticker impact
Cantor Fitzgerald reiterated an Overweight rating on Salesforce with a new $300 price target, implying a 23.7% upside.
upward pressure as investors price in the $300 target
The new target is materially above current price and reflects expected revenue boost from the BRZE acquisition.
Market effects
Positive outlook for the broader CRM and enterprise software sector as the acquisition is seen as a growth catalyst.
U.S. tech equities may see modest uplift.
Limited to investors tracking Salesforce and comparable SaaS firms.
Counterpoint
The $1B revenue contribution from BRZE may be overestimated; integration risk could temper upside.
Key entities
- CompanySalesforce
Provider of CRM software, ticker CRM.
- Research FirmCantor Fitzgerald
Issued the Overweight rating and price target.
- CompanyBRZE
Target of Salesforce's acquisition expected to add $1B in subscription revenue.
